FDA Approves New Sleep Drug With Claims Of Less Risk Of Unpleasant Side Effects

In studies, the drug was found to statistically improve sleep onset and maintain when compared to the placebo. Dayvigo was also not found to cause rebound insomnia, a common problem with some sleep medications.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news